TLD is irrelevant. Phase2 is happening, that's relevant.
EddyA: In support of our readiness for Phase II clinical trials,... We remain committed to our corporate goal of initiating our Phase II studies by the end of 2014.
PW: Our mission is simple. It is to execute ruthlessly;
TLD is best downplayed now that phase2 is happening enough to be in what amounts to final planning stages. End of 2014 is four months, that final.
The only ruthless point of phase1 was to get to phase2. So everything associated with phase1 is now moot.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.